Luca Falzone

20.9k total citations · 3 hit papers
101 papers, 5.3k citations indexed

About

Luca Falzone is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Luca Falzone has authored 101 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 33 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Luca Falzone's work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (14 papers) and Epigenetics and DNA Methylation (11 papers). Luca Falzone is often cited by papers focused on MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (14 papers) and Epigenetics and DNA Methylation (11 papers). Luca Falzone collaborates with scholars based in Italy, Greece and United States. Luca Falzone's co-authors include Massimo Libra, Saverio Candido, Salvatore Salomone, Rossella Salemi, Demetrios�� Spandidos, Giuseppe Gattuso, Silvia Vivarelli, James A. McCubrey, Francesco Torino and Giulia C. Leonardi and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Luca Falzone

97 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

2018 622 citations Luca Falzone, Massimo Libra et al. profile →
Cutaneous melanoma: From pathogenesis to therapy (Review)

2018 428 citations Luca Falzone, Demetrios�� Spandidos et al. profile →
Gut Microbiota and Cancer: From Pathogenesis to Therapy

2019 408 citations Silvia Vivarelli, Saverio Candido et al. profile →

Peers

Countries citing papers authored by Luca Falzone

Since Specialization

Citations

This map shows the geographic impact of Luca Falzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Falzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Falzone more than expected).

Fields of papers citing papers by Luca Falzone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Falzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Falzone. The network helps show where Luca Falzone may publish in the future.

Co-authorship network of co-authors of Luca Falzone

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Falzone. A scholar is included among the top collaborators of Luca Falzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Falzone. Luca Falzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies 2025 ·Medical Oncology ·(unknown), Muhammad Javed Iqbal, (unknown), Ammara Khalid, Hernán Cortés, Octavio D. Reyes‐Hernández, Gabriela Figueroa‐González, Gerardo Leyva‐Gómez, Luca Falzone, Massimo Libra, (unknown), Javad Sharifi‐Rad, Daniela Călina	1
2	Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 2024 ·Journal of Personalized Medicine ·Alessandro Lavoro, (unknown), Giuseppe Gattuso, (unknown), Luca Falzone, Saverio Candido, Massimo Libra, Mario Salmeri	7
3	Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 2024 ·International Journal of Molecular Medicine ·Giuseppe Gattuso, Alessandro Lavoro, Rosario Caltabiano, Gabriele Madonna, Mariaelena Capone, Paolo A. Ascierto, Luca Falzone, Massimo Libra, Saverio Candido	11
4	Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia 2024 ·International Journal of Molecular Sciences ·(unknown), Giorgio Ivan Russo, Rosario Leonardi, (unknown), Giuseppe Gattuso, Luca Falzone, (unknown), A Caponnetto, Rosalia Battaglia, Massimo Libra, Davide Barbagallo, Cinzia Di Pietro, Salvatore Pernagallo, Cristina Barbagallo, Marco Ragusa	5
5	Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 2024 ·Journal of Translational Medicine ·Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, G. Conti, Rosario Caltabiano, Gabriele Madonna, Mariaelena Capone, James A. McCubrey, (unknown), Massimo Libra, Saverio Candido	2
6	Predictive and prognostic biomarkers in cancer: towards the precision medicine era 2024 ·SHILAP Revista de lepidopterología ·Stefano Marletta, (unknown), (unknown), Luca Falzone	4
7	Thapsigargin and its prodrug derivatives: exploring novel approaches for targeted cancer therapy through calcium signaling disruption 2024 ·Medical Oncology ·(unknown), Muhammad Umer Khan, S.M. Ibrahim, Muhammad Usman Ghani, Iram Amin, Luca Falzone, Jesús Herrera‐Bravo, William N. Setzer, Javad Sharifi‐Rad, Daniela Călina	9
8	Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 2023 ·Pharmaceutics ·(unknown), Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Călina, Massimo Libra, Luca Falzone	13
9	Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches 2023 ·Nutrients ·(unknown), (unknown), Giuseppe Gattuso, (unknown), Gabriella Marsala, Daniela Călina, Massimo Libra, Luca Falzone	20
10	Chronic Pesticide Exposure in Farm Workers Is Associated with the Epigenetic Modulation of hsa-miR-199a-5p 2022 ·International Journal of Environmental Research and Public Health ·Giuseppe Gattuso, Luca Falzone, Chiara Costa, Federica Giambò, Michele Teodoro, Silvia Vivarelli, Massimo Libra, Concettina Fenga	6
11	Preserved central cholinergic functioning to transcranial magnetic stimulation in de novo patients with celiac disease 2021 ·PLoS ONE ·Giuseppe Lanza, Francesco Fisicaro, (unknown), Raffaele Ferri, Mariagiovanna Cantone, Luca Falzone, Giovanni Pennisi, Rita Bella, Marios Hadjivassiliou, Manuela Pennisi	6
12	Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma 2021 ·Journal of Personalized Medicine ·Veronica Filetti, Carla Loreto, Luca Falzone, Claudia Lombardo, Emanuele Cannizzaro, Sergio Castorina, Caterina Ledda, Venerando Rapisarda	15
13	Intracortical and Intercortical Motor Disinhibition to Transcranial Magnetic Stimulation in Newly Diagnosed Celiac Disease Patients 2021 ·Nutrients ·Francesco Fisicaro, Giuseppe Lanza, (unknown), Raffaele Ferri, Mariagiovanna Cantone, Luca Falzone, Giovanni Pennisi, Rita Bella, Manuela Pennisi	8
14	Genetic and Epigenetic Alterations Induced by Pesticide Exposure: Integrated Analysis of Gene Expression, microRNA Expression, and DNA Methylation Datasets 2021 ·International Journal of Environmental Research and Public Health ·Federica Giambò, (unknown), Giuseppe Gattuso, (unknown), (unknown), Diana Cinà, Michele Teodoro, Chiara Costa, Aristides Tsatsakis, Concettina Fenga, Luca Falzone	50
15	Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme 2021 ·Pharmaceuticals ·(unknown), Luca Falzone, A Caponnetto, Giuseppe Gattuso, Cristina Barbagallo, Rosalia Battaglia, Federica Mirabella, Giuseppe Broggi, Roberto Altieri, Francesco Certo, Rosario Caltabiano, Giuseppe Barbagallo, Paolo Musumeci, Marco Ragusa, Cinzia Di Pietro, Massimo Libra, Michele Purrello, Davide Barbagallo	83
16	Anti-Candidal Activity of the Parasitic Plant Orobanche crenata Forssk 2021 ·Antibiotics ·Floriana D’Angeli, Fiorella Guadagni, Carlo Genovese, Daria Nicolosi, Angela Trovato Salinaro, Mariarita Spampinato, Giuliana Mannino, Debora Lo Furno, Giulio Petronio Petronio, Simone Ronsisvalle, (unknown), Luca Falzone, Vittorio Calabrese	5
17	Novel Insights into Epigenetic Regulation of IL6 Pathway: In Silico Perspective on Inflammation and Cancer Relationship 2021 ·International Journal of Molecular Sciences ·Saverio Candido, Barbara Tomasello, Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, Massimo Libra	36
18	SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 2020 ·Food and Chemical Toxicology ·Aristides Tsatsakis, Daniela Călina, Luca Falzone, Dimitrios Petrakis, Radu Mitruţ, Vasileios Siokas, Manuela Pennisi, Giuseppe Lanza, Massimo Libra, Sotirios G. Doukas, Panagiotis G. Doukas, (unknown), (unknown), Chiranjeevi Gadiparthi, Dimitra P. Vageli, Diamantis P. Kofteridis, Demetrios�� Spandidos, Mônica Maria Bastos Paoliello, Michael Aschner, Anca Oana Docea	113
19	SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms 2020 ·International Journal of Molecular Sciences ·Manuela Pennisi, Giuseppe Lanza, Luca Falzone, Francesco Fisicaro, Raffaele Ferri, Rita Bella	119
20	Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics 2019 ·Cells ·(unknown), Luca Falzone, Massimo Libra, О. И. Гурина, (unknown), Τaxiarchis Κonstantinos Νikolouzakis, Alexander E. Nosyrev, Chris W. Sutton, Panayiotis Mitsias, Aristides Tsatsakis	183

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact